<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public" slc-id="S1-TAM23K72-54X-02-YC7"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 S3462 IS: To require the Secretary of Health and Human Services to issue draft guidance to address non-addictive analgesics for chronic pain.</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2023-12-11</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">II</distribution-code><congress>118th CONGRESS</congress><session>1st Session</session><legis-num>S. 3462</legis-num><current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber><action><action-date date="20231211">December 11, 2023</action-date><action-desc><sponsor name-id="S411">Mr. Marshall</sponsor> (for himself, <cosponsor name-id="S369">Mr. Markey</cosponsor>, and <cosponsor name-id="S372">Mrs. Capito</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSHR00">Committee on Health, Education, Labor, and Pensions</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title>To require the Secretary of Health and Human Services to issue draft guidance to address non-addictive analgesics for chronic pain.</official-title></form><legis-body><section id="id6883fee775914b80a075b39184f6a52a" section-type="section-one"><enum>1.</enum><header>Guidance on developing non-addictive medical products to treat pain or addiction</header><text display-inline="no-display-inline">Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services shall issue draft guidance under section 3001(b) of the SUPPORT for Patients and Communities Act (<external-xref legal-doc="usc" parsable-cite="usc/21/355">21 U.S.C. 355</external-xref> note) to address non-addictive analgesics for chronic pain, including the information required to be included in guidance documents under paragraphs (1) through (4) of such section 3001(b).</text></section></legis-body></bill> 

